Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Descovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in an open- label clinica
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.8 · Most of these adverse reactions were grade 1 and occurred after 8 weeks.
Eintrag öffnenDupixent · 4.8 · 15 Asthma The safety profile of dupilumab in the 96 weeks long term safety study (TRAVERSE) was consistent wit
Eintrag öffnenDupixent · 4.8 · 77 The safety profile of dupilumab in the 96 weeks long term safety study (TRAVERSE) was consistent with the s
Eintrag öffnenDupixent · 4.8 · Approximately 8% of patients with COPD who received dupilumab 300 mg Q2W for 52 weeks developed antibodies to
Eintrag öffnenDupixent · 4.8 · Approximately 8% of patients with COPD who received dupilumab 300 mg Q2W for 52 weeks developed antibodies to
Eintrag öffnenDupixent · 4.8 · Approximately 9 % of patients with asthma who received dupilumab 200 mg Q2W for 52 weeks developed antibodies
Eintrag öffnenDupixent · 4.8 · Approximately 9 % of patients with asthma who received dupilumab 200 mg Q2W for 52 weeks developed antibodies
Eintrag öffnenDupixent · 4.8 · The safety profile of dupilumab in children with asthma 6 to 11 years of age who participated in the 52 weeks
Eintrag öffnenDupixent · 4.8 · The safety profile of dupilumab in children with asthma 6 to 11 years of age who participated in the 52 weeks
Eintrag öffnenEbglyss · 4.8 · During the first 16 weeks of treatment conjunctivitis, conjunctivitis allergic, blepharitis and keratitis were
Eintrag öffnenEdurant · 4.8 · 33 in the rilpivirine arm and efavirenz arm was 104.3 and 104.1 weeks, respectively. Most ADRs occurred in the
Eintrag öffnenEfavirenz Teva · 4.8 · Analysis of long-term data showed that, beyond 24 weeks of therapy, the incidences of new-onset nervous system
Eintrag öffnenEfavirenz Teva · 4.8 · Rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first two weeks of init
Eintrag öffnenElahere · 4.8 · The median time to onset for first ocular adverse reaction was 5.1 weeks (range: 0.1 to 68.6). Of the patients
Eintrag öffnenElahere · 4.8 · The median time to onset of peripheral neuropathy was 5.9 weeks (range 0.1 to 126.7). Peripheral neuropathy re
Eintrag öffnenElahere · 4.8 · The median time to onset of pneumonitis was 18.1 weeks (range 1.6 to 97.0). Pneumonitis resulted in mirvetuxim
Eintrag öffnenEnspryng · 4.8 · Elevations of ALT above 5 x ULN were observed 4 weeks after initiation of therapy in one (1%) patient receivin
Eintrag öffnenEntecavir Accord · 4.8 · Treatment beyond 48 weeks: continued treatment with entecavir for a median duration of 96 weeks did not reveal
Eintrag öffnenEpidyolex · 4.8 · In the clinical trials, the first onset of diarrhoea was typically in the first 6 weeks of treatment with cann
Eintrag öffnen